Navigation Links
ChanTest Announces Third User Meeting: Partnerships in Drug Discovery
Date:8/6/2013

Cleveland, OH (PRWEB) August 06, 2013

Partnerships between industry and vendors have a positive impact on the drug discovery industry when the right companies come together, as they allow for innovation and optimize the process of identifying the right drugs faster and more effectively. On Friday, September 27, 2013, ChanTest will host a third User Meeting: "Partnerships in Drug Discovery" to be held at the Westin Boston Waterfront Hotel, 425 Summer Street, Boston, MA.

The keynote speaker of this complimentary event will be Christopher Penland, Ph.D., Senior Director of Research at the Cystic Fibrosis Foundation, who will speak about the Foundation’s efforts to work with the scientific community to find new solutions for cystic fibrosis.Other presentations will highlight ion channels for pain drug discovery and neuropathology, the development of gut-targeted therapeutics, and strategies for merging automated patch clamp techniques with high-throughput screening.

"We are again looking forward to bringing together a range of experts from safety and discovery labs to highlight their work and the value of their collaborations with ChanTest," explained Chris Mathes, Ph.D., Chief Commercial Officer at ChanTest.

The event is co-sponsored by Acea Biosciences, Axion Biosystems, AxioGenesis, Battelle, Cellular Dynamics International, Molecular Devices, Renovo Neural, Sophion and Sygnature Discovery.

Register to attend.

Friday, September 27, 2013
3rd ChanTest User Meeting: Partnerships in Drug Discovery
Westin Boston Waterfront Hotel
425 Summer Street
Boston, MA 02210

FURTHER INFORMATION
ChanTest
14656 New Parkway
Cleveland, Ohio 44128
1-877-828-1777 Toll Free
1-216-332-1665 Tel
1-216-332-1706 Fax
info(at)chantest(dot)com

Contact for Media Inquiries:
Chris Mathes, Ph.D., M.B.A.
Chief Commercial Officer
cmathes(at)chantest(dot)com
http://www.chantest.com

About ChanTest® – The Ion Channel Expert

ChanTest’s mission is to serve the drug discovery and development needs of customers worldwide with high-value solutions for ion channel and GPCR biology. Since its inception in 1998, the CRO has tested compounds for more than 300 global pharmaceutical and biotechnology companies, and partners with them to speed the drug development process for the release of better, safer drugs.

ChanTest offers integrated ion channel and GPCR services (GLP and non-GLP) and reagents; the company’s library of validated ion channel cell lines and nonclinical cardiac risk assessment service portfolio is the most comprehensive commercially available today.

Because of ChanTest’s seminal role in the nonclinical cardiac safety field, along with the company’s uncompromising commitment to quality, ChanTest has been named the "most trusted and most used fee-for-service provider" for ion channel screening in an independent survey over the past eight years. ChanTest is based in Cleveland, Ohio. Visit http://www.chantest.com to learn more about what we do.

Read the full story at http://www.prweb.com/releases/2013/8/prweb10997636.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. ChanTest Announces ChansPorter™ Assays to Accelerate Drug Development for Cystic Fibrosis Patients
2. New Teeth Whitening Procedure Effective On Teeth of Elderly, and Darkly Stained by Tetracycline, San Antonio Cosmetic Dentist Edward Camacho Announces
3. Diet Doc Weight Loss Plans Announces New Fat Burning Foods That Allow Patients to Lose Weight Fast and Decrease Bone Marrow Fat
4. Migraine Research Foundation Announces Newly Expanded and Updated Headache Doctor Lists
5. Leading Shopping Cart Software Expert, Shopping Cart Elite, Officially Announces The Launch Of Ebridalsuperstore.com.
6. Help Desk Software Provider iSupport Software Announces Version 12.5
7. hCGTreatments / Diet Doc Prescription Weight Loss Plans Announces New Quick Weight Loss Supplement 7-Keto DHEA Designed To Accelerate Results Naturally
8. hCGTreatments / Diet Doc Weight Loss Diets Announces Medical Diet Plans Designed to Promote Fast Weight Loss While Lowering Cholesterol Levels
9. Internet Marketing Firm Web-Op Announces Launch of KingSupplements.com
10. Clay Park Tower Apartments, One of San Francisco’s Top Pacific Heights Apartment Complexes, Announces 100% Occupancy
11. Spectrum Surgical Announces Dual-Chuck® Orthopedic Pin Insertion Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2016)... ... April 30, 2016 , ... Orlando-based Maximized Living has ... go for gold in Rio. Under the care of Maximized Living doctors at ... In an unprecedented showing, Maximized Living is sending the largest contingent of elite chiropractors ...
(Date:4/29/2016)... ... April 29, 2016 , ... Memorial ... for Graduate Medical Education (ACGME) that it has received accreditation for its residency ... of three residency programs that Memorial is currently pursuing, including Pediatrics and Internal ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Bernie Siegel, ... "LOVE, MEDICINE and MIRACLES") addresses touchy topics related to Death live on ... Dr. Bernie Siegel, author of a plethora of essential books-to-read for physicians ...
(Date:4/29/2016)... ... ... Spine Team Texas, a comprehensive spine physician group specializing in the treatment of ... invited to be a featured speaker at the Texas Society of the American College ... , Dr. R. Scott McPherson, a physical medicine and rehabilitation specialist, will speak ...
(Date:4/29/2016)... ... ... the deadliest type of skin cancer. Although only about 1 percent of skin cancer cases ... 10,000 people are expected to die of melanoma this year. The risk increases with age, ... most commonly diagnosed cancers in young women. A recent breakthrough in genetic studies may give ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... April 29, 2016 Glycotope GmbH, ... today announces the appointment of Dr. Alfredo Zurlo ... is an oncologist with many years clinical experience and ... industries. His last role was at Mologen AG where ... Executive Board. Previously Dr. Zurlo held various positions at ...
(Date:4/28/2016)...  While Abbott,s announced purchase of St. Jude ... and stent business, healthcare research firm Kalorama Information ... into patient monitoring.  Kalorama said that patient monitoring ... with double-digit growth expected the next 5 years, ... Patient Monitoring . Abbott Laboratories agreed to ...
(Date:4/28/2016)... 2016 Dr. ... und Stephen Schmidt werden ... ArisGlobal®, ein führender Anbieter cloudbasierter Softwarelösungen für ... dass neue Führungskräfte zum Team Sicherheit und ... vielfältige Erfahrungen mitbringen.  Dies wird die Geschäftseinheit ...
Breaking Medicine Technology: